DrugDashboards

Se-Natal 19

.beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium · .BETA.-CAROTENE 1000 [iU]/1; ASCORBIC ACID 100 mg/1; CHOLECALCIFEROL 400 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 30 mg/1; THIAMINE 3 mg/1; RIBOFLAVIN 3 mg/1; NIACINAMIDE 15 mg/1; PYRIDOXINE HYDROCHLORIDE 20 mg/1; FOLIC ACID 1 mg/1; CYANOCOBALAMIN 12 ug/1; CALCIUM PANTOTHENATE 7 mg/1; CALCIUM CARBONATE 200 mg/1; FERROUS FUMARATE 29 mg/1; ZINC OXIDE 20 mg/1; DOCUSATE SODIUM 25 mg/1 · Tablet · Oral · Seton Pharmaceuticals

NDC 13925-0116-01 · 100 TABLET in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is up 8% over the past year, to $0.4737 per unit. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.4737per EAinvoice-surveyed acquisition cost · Jun 17, 2026
  • Part D plans paid (avg)$0.6911per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Nov 2013Sep 2026$0.4737
44 price points · per EA · held since Invalid DateSource: CMS NADAC

Estimated fill cost

#30 count
$14.21
#90 count
$42.64

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$1.1M
39,217 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.0%chance of a new FDA shortage posting for .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium (oral solid) in the next 90 days

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium (Tablet)

LabelerStrengthFirst seenLast seen
Seton Pharmaceuticals.BETA.-CAROTENE 1000 [iU]/1; ASCORBIC ACID 100 mg/1; CHOLECALCIFEROL 400 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 30 mg/1; THIAMINE 3 mg/1; RIBOFLAVIN 3 mg/1; NIACINAMIDE 15 mg/1; PYRIDOXINE HYDROCHLORIDE 20 mg/1; FOLIC ACID 1 mg/1; CYANOCOBALAMIN 12 ug/1; CALCIUM PANTOTHENATE 7 mg/1; CALCIUM CARBONATE 200 mg/1; FERROUS FUMARATE 29 mg/1; ZINC OXIDE 20 mg/1; DOCUSATE SODIUM 25 mg/1Aug 26, 2026Sep 2, 2026
Seton Pharmaceuticals.BETA.-CAROTENE 30 mg/1; ASCORBIC ACID 1000 [iU]/1; CHOLECALCIFEROL 100 mg/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 200 mg/1; THIAMINE 7 mg/1; RIBOFLAVIN 400 [iU]/1; NIACINAMIDE 12 ug/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; FOLIC ACID 29 mg/1; CYANOCOBALAMIN 1 mg/1; CALCIUM PANTOTHENATE 15 mg/1; CALCIUM CARBONATE 20 mg/1; FERROUS FUMARATE 3 mg/1; ZINC OXIDE 3 mg/1; DOCUSATE SODIUM 20 mg/1Jul 22, 2026Aug 19, 2026
Seton Pharmaceuticals.ALPHA.-TOCOPHEROL ACETATE, DL- 30 mg/1; .BETA.-CAROTENE 1000 [iU]/1; ASCORBIC ACID 100 mg/1; CALCIUM CARBONATE 200 mg/1; CALCIUM PANTOTHENATE 7 mg/1; CHOLECALCIFEROL 400 [iU]/1; CYANOCOBALAMIN 12 ug/1; DOCUSATE SODIUM 25 mg/1; FERROUS FUMARATE 29 mg/1; FOLIC ACID 1 mg/1; NIACINAMIDE 15 mg/1; PYRIDOXINE HYDROCHLORIDE 20 mg/1; RIBOFLAVIN 3 mg/1; THIAMINE 3 mg/1; ZINC OXIDE 20 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Se-Natal 19 — NDC 13925-0116-01," retrieved September 3, 2026, https://drugdashboards.com/drug/13925011601.

Free to cite with attribution — see how the data is put together.